Adalimumab (Indonesian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Adalimumab" in Indonesian language version.
refsWebsite
Global rank
Indonesian rank
1st place
1st place
719th place
1,112th place
102nd place
411th place
drugs.com
- "Adalimumab Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. 14 May 2018. Diarsipkan dari versi asli tanggal 21 November 2020. Diakses tanggal 18 March 2019.
- "Adalimumab Pregnancy and Breastfeeding Warnings". Drugs.com. Diarsipkan dari versi asli tanggal 17 April 2021. Diakses tanggal 19 March 2019.
fda.gov
accessdata.fda.gov
- "Drug Approval Package: Humira (adalimumab)". U.S. Food and Drug Administration (FDA). 7 April 2017. Diarsipkan dari versi asli tanggal 18 February 2020. Diakses tanggal 18 February 2020.
handle.net
hdl.handle.net
- World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771
. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
medscape.com
- "FDA Clears Adalimumab (Humira) for Hidradenitis Suppurativa". Medscape. 11 September 2015. Diarsipkan dari versi asli tanggal 21 January 2021. Diakses tanggal 13 October 2017.
web.archive.org
- "Adalimumab Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. 14 May 2018. Diarsipkan dari versi asli tanggal 21 November 2020. Diakses tanggal 18 March 2019.
- "FDA Clears Adalimumab (Humira) for Hidradenitis Suppurativa". Medscape. 11 September 2015. Diarsipkan dari versi asli tanggal 21 January 2021. Diakses tanggal 13 October 2017.
- "Adalimumab Pregnancy and Breastfeeding Warnings". Drugs.com. Diarsipkan dari versi asli tanggal 17 April 2021. Diakses tanggal 19 March 2019.
- "Drug Approval Package: Humira (adalimumab)". U.S. Food and Drug Administration (FDA). 7 April 2017. Diarsipkan dari versi asli tanggal 18 February 2020. Diakses tanggal 18 February 2020.